Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
25.40%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
57.16
EV to EBIT
-75.28
EV to EBITDA
-77.32
EV to Capital Employed
-135.29
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-73.02%
0What is working for the Company
NO KEY POSITIVE TRIGGERS
-6What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -1.9 MM has Fallen at -53.51%
NET PROFIT(Q)
At USD -1.9 MM has Fallen at -53.51%
Here's what is not working for Turn Therapeutics, Inc.
Pre-Tax Profit
At USD -1.9 MM has Fallen at -53.51%
over average net sales of the previous four periods of USD -1.24 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -1.9 MM has Fallen at -53.51%
over average net sales of the previous four periods of USD -1.24 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)






